Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1932041000168114 | cytarabine 50 mg / 5 mL modified release injection, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1932051000168111 | cytarabine 50 mg/5 mL modified release injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cytarabine 50 mg/5 mL modified release injection, vial | Is a | cytarabine | true | Inferred relationship | Some | ||
| cytarabine 50 mg/5 mL modified release injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| cytarabine 50 mg/5 mL modified release injection, vial | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| cytarabine 50 mg/5 mL modified release injection, vial | has unit of use | vial | true | Inferred relationship | Some | 748033273 | |
| cytarabine 50 mg/5 mL modified release injection, vial | has intended active ingredient | cytarabine | true | Inferred relationship | Some | 748033272 | |
| cytarabine 50 mg/5 mL modified release injection, vial | has Australian BoSS | cytarabine | true | Inferred relationship | Some | 748033272 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Depocyt 50 mg/5 mL modified release injection, 5 mL vial | Is a | True | cytarabine 50 mg/5 mL modified release injection, vial | Inferred relationship | Some | |
| cytarabine 50 mg/5 mL modified release injection, 5 mL vial | has MPUU | True | cytarabine 50 mg/5 mL modified release injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR